By Michael Borella — As patent-eligibility stands in 2018, it can be difficult to determine whether a graphical user interface (GUI) with an innovative layout and/or functionality meets the requirements of 35 U.S.C. § 101. On one hand, a GUI is almost by definition fundamentally tied to computer operation, and arguably has no non-computer analog. On the other hand, a GUI that merely displays data in a non-specific layout is likely going to be viewed as a generic technical environment or just extra-solution activity. In the Federal Circuit, recent cases addressing the eligibility of GUIs have found those claimed at…Original Article
You may also like
Pharmaceutical Sales Customer Engagement –...
AstraZeneca’s Polyneuropathy Treatment Recommended...
Designing a Strategic Roadmap for Seamless Product...
AAPS PharmSci 360: LBFs and Tackling Oral Biologic...
CHMP Gives Positive Opinion to Novo Nordisk Hemophilia...
GSK, Cambridge to Partner on R&D for Kidney and...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.